GB1061898A - Method for protecting dogs against canine distemper - Google Patents

Method for protecting dogs against canine distemper

Info

Publication number
GB1061898A
GB1061898A GB9604/64A GB960464A GB1061898A GB 1061898 A GB1061898 A GB 1061898A GB 9604/64 A GB9604/64 A GB 9604/64A GB 960464 A GB960464 A GB 960464A GB 1061898 A GB1061898 A GB 1061898A
Authority
GB
United Kingdom
Prior art keywords
distemper
against canine
months
administered
age
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB9604/64A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Philips Electronics and Pharmaceutical Industries Corp
Original Assignee
Philips Electronics and Pharmaceutical Industries Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philips Electronics and Pharmaceutical Industries Corp filed Critical Philips Electronics and Pharmaceutical Industries Corp
Publication of GB1061898A publication Critical patent/GB1061898A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/165—Mumps or measles virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Dogs are protected against canine distemper by administering heterotypic measles virus to the young dog, and then vaccinating the dog with distemper virus after maternally transferred distemper antibody has disappeared sufficiently and allow for effective immunization. The preferred measles virus is a live attenuated form, produced by serial passage through canine kidney cell cultures; it is administered at an age from two weeks to four months after birth. The distemper vaccine, which is administered at an age of over four months, is suitably a homotypic vaccine.
GB9604/64A 1963-03-07 1964-03-06 Method for protecting dogs against canine distemper Expired GB1061898A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26349463A 1963-03-07 1963-03-07

Publications (1)

Publication Number Publication Date
GB1061898A true GB1061898A (en) 1967-03-15

Family

ID=23002004

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9604/64A Expired GB1061898A (en) 1963-03-07 1964-03-06 Method for protecting dogs against canine distemper

Country Status (1)

Country Link
GB (1) GB1061898A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6183750B1 (en) 1981-12-24 2001-02-06 Health Research, Inc. Avipox virus containing DNA sequences encoding herpesvirus glycoproteins
US6605465B1 (en) 1989-04-17 2003-08-12 Health Research, Inc. Methods for avoiding maternal immunity

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6183750B1 (en) 1981-12-24 2001-02-06 Health Research, Inc. Avipox virus containing DNA sequences encoding herpesvirus glycoproteins
US6605465B1 (en) 1989-04-17 2003-08-12 Health Research, Inc. Methods for avoiding maternal immunity

Similar Documents

Publication Publication Date Title
Abelseth An attenuated rabies vaccine for domestic animals produced in tissue culture
RU2020119271A (en) VACCINE FOR PROTECTION AGAINST STREPTOCOCCUS SUIS
Park et al. Immune responses in pigs and cattle vaccinated with half-volume foot-and-mouth disease vaccine
Lawson et al. The ERA strain of rabies vaccine
RU2020109137A (en) VACCINE FOR PROTECTION AGAINST STREPTOCOCCUS SUIS
GB1061898A (en) Method for protecting dogs against canine distemper
Hale et al. The Intracranial Toxicity of Influenza Virus for Mice.
US4040904A (en) Novel rabies virus vaccine and processes
GB1071922A (en) Improvements in or relating to vaccines
US3479430A (en) Indirect passive immunization against transmissible gastroenteritis virus in nursing piglets at birth by active immunization of sows prior to farrowing with transmissible gastroenteritis vaccine and method of producing the same
Erickson et al. A field comparison of heterologous and homologous routes of administration of modified live vaccines for the control of bovine respiratory disease in recently weaned beef calves
GB1058340A (en) Transmissible gastroenteritis vaccines and method of producing the same
Dalsgaard et al. Saponin adjuvants. VI. The adjuvant activity of quil A in trivalent vaccination of cattle and guinea pigs against foot-and-mouth disease
US3704203A (en) Transmissible gastroenteritis vaccines and methods of producing the same
Song et al. Guidelines for vaccination of dogs and cats in Korea
Caldwell Beef cattle reproductive herd health
Hannant Immune responses to common respiratory pathogens: problems and perspectives in equine immunology
DE1692043C3 (en) Rhinopneumonitis vaccines and processes for their manufacture
Coggins et al. Serological Comparison with Rabbit Antisera of Hog Cholera Virus and Bovine Virus Diarrhea Virus.
Menšík et al. Development of Antibody Response to Swine Influenza Virus in Pigs: I. The Influence of Experimental Infection of Pregnant Sows on Serum Antibody Production by their Progeny during Postnatal Development
US3106514A (en) Measles virus immunization with gamma globulin administered simultaneously with measles virus vaccine
US3346456A (en) Immunizing pigs against hog cholera with selected strains of live virus diarrhea virus and preparation of virus diarrhea virus hyper-immune hog cholera serum
US3255081A (en) Anti-viral vaccines immunized against oncogenic viruses
AT248791B (en) Method of protecting dogs from distemper
RU2532320C1 (en) Method for vaccinal prevention of respiratory diseases in calves